Despite NVIDIA's compelling Vera Rubin product cycle narrative, the stock faces a confluence of macro headwinds — Trump tariff escalation, AI capex scrutiny, Mag Seven rotation, and US debt market stress — that are being systematically underpriced by the market. At $206.84, NVDA trades near recent swing highs after a sharp three-session recovery driven largely by benchmark hype from a single commercially-aligned partner (CoreWeave), while the broader AI infrastructure spending thesis faces its most serious fundamental challenge yet. The contrarian bet is that macro deterioration and capex skepticism will overwhelm product cycle optimism over the next 2-3 months, pulling NVDA back toward its recent consolidation lows.